Deciphering Your Pathology Report
At a Glance
An intraductal papilloma pathology report should be read alongside the breast imaging report. Atypia, BI-RADS concordance, adequate sampling, and any remaining abnormality help doctors decide whether monitoring, repeat biopsy, or surgical removal is appropriate.
The pathology report provides vital information about the tissue sampled during your biopsy. While your doctor will summarize the results, understanding the specific language used by the pathologist—the doctor who studies your tissue under a microscope—can help you participate more actively in your care decisions. Note that a well-sampled, concordant core can be sufficient, but the absence of atypia does not override a separate report of more advanced findings.
Decoding “Atypia”
An important word on your report is atypia. This refers to cells that look abnormal under a microscope but are not yet cancerous. In the context of a papilloma, atypia usually takes two forms:
- Atypical Ductal Hyperplasia (ADH): This is a growth of abnormal cells that share some features with early-stage cancer but do not meet the full criteria for a cancer diagnosis [1][2].
- Atypical Lobular Hyperplasia (ALH): These are abnormal cells found in the milk-producing glands (lobules) [3].
Finding atypia within or next to a papilloma is significant because it suggests the area is more complex than a simple growth. While a pure, benign papilloma has a lower “upgrade rate” (the chance of finding cancer if the whole area is removed), an atypical papilloma has a much higher upgrade rate, often estimated between 20% and 36% in study cohorts [4][5][6]. For this reason, finding atypia almost always leads to a recommendation for surgical removal [7].
Radiologic-Pathologic Concordance
Your diagnosis is not just based on the biopsy; it’s based on whether the biopsy results match your imaging. This is called concordance [8].
- Concordant: The pathology explains the imaging. If your mammogram showed a 5mm mass and the biopsy found a 5mm benign papilloma, the results are “concordant.” This is reassuring [9].
- Discordant: The pathology does not explain the imaging. For example, if your imaging showed a highly suspicious, irregular mass (BI-RADS 4C or 5) but the biopsy only found a tiny piece of normal tissue, the results are “discordant” [10].
Why it matters: A discordant result means the needle may have missed the most concerning part of the lesion. In cases of discordance, the risk of a significant finding remains elevated, and your doctor will likely recommend a prompt multidisciplinary review, a repeat biopsy, or surgical excision to be certain [10][8].
The Role of Myoepithelial Cells
You may see mentions of immunohistochemistry (IHC) or specific stains like p63 or calponin on your report [11]. These are tools pathologists use to identify myoepithelial cells. These cells form a protective layer around the milk ducts. If this layer is intact, it supports a benign or “in situ” (contained) interpretation. If the layer is missing, it may indicate invasive cancer [12][13]. However, stains can be incomplete, so pathologists rely on them along with architecture and morphology.
Completeness Checklist
When reviewing your report with your doctor, ensure these four data points are clearly addressed:
- Diagnosis: Does it clearly state “Intraductal Papilloma”, and is there any mention of malignancy?
- Atypia Status: Does it explicitly say “no atypia,” or does it mention ADH, ALH, or “atypical features” [12]?
- Concordance Statement: Is the result officially documented as “radiologic-pathologic concordant” [14]?
- Sampling Adequacy: Was the target adequately sampled during the biopsy, and does any residual imaging abnormality remain [15]?
Managing the “Spectrum”
Pathologists view papillary lesions on a spectrum. On one end is the simple, benign papilloma. On the other is papillary carcinoma (cancer). Atypical papillomas sit in the middle [12]. Because a biopsy needle only takes a small sample of the whole growth, the final full diagnosis is sometimes reached after the entire area is removed and examined [14]. If your report is unclear or “borderline,” your doctor may request a second opinion from a breast-specialist pathologist to ensure the most accurate interpretation [16].
Common questions in this guide
What does atypia mean in an intraductal papilloma?
What does radiologic-pathologic concordance mean?
Is a papilloma without atypia always left alone?
Why are p63 and calponin stains used on a papilloma biopsy?
What should I compare in my pathology and breast imaging reports?
When might my papilloma pathology report need a second opinion?
Get notified when new evidence is published on intraductal papilloma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Papillary lesions of the breast: To excise or observe?
Khan S, Diaz A, Archer KJ, et al.
The breast journal 2018; (24(3)):350-355 doi:10.1111/tbj.12907.
PMID: 28845569 - 2
When Does Atypical Ductal Hyperplasia Require Surgical Excision?
Racz JM, Degnim AC
Surgical oncology clinics of North America 2018; (27(1)):23-32 doi:10.1016/j.soc.2017.07.011.
PMID: 29132563 - 3
Patients with benign papilloma diagnosed on core biopsies and concordant pathology-radiology findings can be followed: experiences from multi-specialty high-risk breast lesion conferences in an academic center.
Ma Z, Arciero CA, Styblo TM, et al.
Breast cancer research and treatment 2020; (183(3)):577-584 doi:10.1007/s10549-020-05803-2.
PMID: 32705378 - 4
Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N, Cevik J, Hopkins D, Lippey J
Journal of surgical oncology 2024; (129(6)):1025-1033 doi:10.1002/jso.27592.
PMID: 38305061 - 5
Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
Zhang X, Liu W, Hai T, Li F
Annals of surgical oncology 2021; (28(13)):8643-8650 doi:10.1245/s10434-021-10188-7.
PMID: 34331160 - 6
Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H, Bomeisl P, Amin AL, et al.
Human pathology 2022; (128()):90-100 doi:10.1016/j.humpath.2022.07.012.
PMID: 35863513 - 7
Management of High-Risk Breast Lesions: A Comprehensive Update.
Zamora KW, Komforti MK, Vorhis EB, et al.
Journal of breast imaging 2026; (8(5)):477-494 doi:10.1093/jbi/wbag034.
PMID: 42490060 - 8
Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.
Yincharoen P, Sharma CP, Tawanwongsri W
Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.
PMID: 42201021 - 9
Demystifying Breast Disease Markers.
Wells VA, Medeiros I, Shevtsov A, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(10)):e220151 doi:10.1148/rg.220151.
PMID: 37676826 - 10
Institutional Review of BI-RADS 5 and BI-RADS 4C Lesions Over 5 Years Following Surgical Excision: Analysis of Radiology-Pathology Correlation.
Brodsky JE, Ly M, Jang S, et al.
Journal of breast imaging 2026; (8(5)):540-549 doi:10.1093/jbi/wbag019.
PMID: 42479170 - 11
Clinicopathologic features of intraductal papillary neoplasm of breast: analyses of three cases.
Zhao Y, Li N, Gong X, et al.
International journal of clinical and experimental pathology 2017; (10(9)):9575-9582.
PMID: 31966834 - 12
Pathology of breast papillary neoplasms: Community hospital experience.
Vdovenko AA
Annals of diagnostic pathology 2020; (49()):151605 doi:10.1016/j.anndiagpath.2020.151605.
PMID: 32920473 - 13
Papillary lesions of the breast - review and practical issues.
Ni Y, Tse GM
Seminars in diagnostic pathology 2022; (39(5)):344-354 doi:10.1053/j.semdp.2022.06.001.
PMID: 35718581 - 14
Underestimation of breast cancer in intraductal papillomas treated with vacuum-assisted core needle biopsy.
Hodorowicz-Zaniewska D, Siarkiewicz B, Brzuszkiewicz K, Szpor J
Ginekologia polska 2019; (90(3)):122-127 doi:10.5603/GP.2019.0022.
PMID: 30950000 - 15
Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.
Abbassi-Rahbar S, Sack S, Larson KE, et al.
Annals of surgical oncology 2021; (28(10)):5768-5774 doi:10.1245/s10434-021-10520-1.
PMID: 34338925 - 16
Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.
Prakash S, Venkataraman S, Slanetz PJ, et al.
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):122-9.
PMID: 26632099
This page is for informational purposes only and does not constitute medical advice. Your breast specialist, radiologist, and pathologist should interpret your intraductal papilloma report together and advise you about biopsy or excision.